Onderneming Callitas Health Inc. Canadian Securities Exchange
Aandelen
LILY
CA13125C1068
Biotechnologie & Medisch Onderzoek
Vakgebied
Verkoop per activiteit
CAD in miljoen | 2018 | Gewicht | 2019 | Gewicht | Delta |
---|---|---|---|---|---|
Consumer Health and Wellness Products
100,0
%
| 1 | 100,0 % | 1 | 100,0 % | -5,46% |
Verkoop per regio
CAD in miljoen | 2018 | Gewicht | 2019 | Gewicht | Delta |
---|---|---|---|---|---|
Canada
100,0
%
| 1 | 100,0 % | 1 | 100,0 % | -5,46% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Chief Executive Officer | - | 03-01-18 | |
Robert Payment
DFI | Director of Finance/CFO | 42 | - |
Brian Keane
BRD | Director/Board Member | 47 | - |
Joshua Maurice
SAM | Sales & Marketing | - | 01-09-17 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Donald Skeith
BRD | Director/Board Member | 69 | 01-12-14 |
William Rodgers
BRD | Director/Board Member | - | - |
Brian Keane
BRD | Director/Board Member | 47 | - |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 45 271 962 | 32 615 816 ( 72,04 %) | 0 | 72,04 % |
Bedrijfsgegevens
Callitas Health, Inc.
187 Pavilion Parkway Suite 200
41071, Newport
+859 868 3131
http://www.callitas.com![Adres Callitas Health Inc.(LILY)](https://cdn.zonebourse.com/static/address/38066221.png)
Sector
Verkoop per regio
Vaira. 1 jan. | Kapi. | |
---|---|---|
+21,85% | 46,93 mld. | |
+37,63% | 39,08 mld. | |
-8,05% | 38,48 mld. | |
+29,04% | 31,01 mld. | |
-13,75% | 26,14 mld. | |
+10,65% | 25,88 mld. | |
+38,43% | 12,53 mld. | |
-6,92% | 11,36 mld. | |
-12,29% | 10,65 mld. |